You are currently browsing the archives for 12 July 2016.
Displaying 1 - 2 of 2 entries.

While more research needs to be done.

While more research needs to be done, this new target result to an innovative therapeutic approach to fight the AIDS pandemic.###. This news release is available in French Jean-Pierre Routy is a practitioner in the Division of Hematology at the MUHC and a researcher in the Infection and Immunity axis at the Research Institute of the MUHC. He also an associate professor of hematology at McGill University and a senior clinical researcher with the Fonds de la recherche en is sant? bec .

Present methods allow cells based on whether they emit fluorescent light when they are with a marker The new system allowspecific to a protein or other compound reacts to sort mixed. The new system allows more precise sorting, separating cells based not just on the overall average fluorescent response of the whole cell but on responses that. In certain parts of the cell, as occurs, for example, the core The system can also collect answers, how fast they begin or how long it will vary. – ‘We were interested in looking at things inside the cell, the change either over time or in certain places,’Voldman says. Isolation of cells with such characteristics ‘can not be done with traditional cell sorting. ‘ For example, if how fast they how fast they used to a particular compound in the fluorescent label different, the new system would make it possible to ‘select those that are faster or slower, and see what is different,’says Voldman which also dates in MIT Research Laboratory of Electronics and the Microsystems Technology Laboratories.

The other half will drug counseling drug counseling session from their doctors.

In addition, effectiveness of different effectiveness of different behavioral therapies in combination with the drug, half of the subjects will be intensive individual intensive individual drug counseling program when they get their prescriptions. The other half will drug counseling drug counseling session from their doctors. The patients, all study treatments, medications, receive at no cost and will be compensated for their time.

Notices for example, de Pillis is an important but open question as to combine as best on several cancer treatments in a patient ‘Should we first strengthen the immune system, and then give toxic chemotherapy, we should large doses from treatment from treatment and small doses of another and how we should combine those treatments, how long before re – before re – administration of a toxic treatment ‘.